Moreover, the post-translational modifications of NPM1 affect the therapeutic response in AML, whereby SENP3-mediated deSUMOylation of NPM1 induced the resistance of AML cells to chemo- and radiotherapy [36]. The gene discussed is SENP3; the disease is acute myeloid leukemia.